Although extracellular vesicles, oxidized phospholipids, secreted proteins, and lipid-derived electrophilic metabolites all represent plausible candidates, it remains unclear which mediators possess sufficient stability and diffusivity to support propagation across anatomically separated yet functionally connected cells
A personalized formulation of glutathione, vitamin C, hydration fluids and (where indicated) supportive cofactors is then prescribed and compounded with pharmacy-grade ingredients
Shoemaker, who tested this product, describes it as fruity, mild, and not overly sweet, with a pleasantly thin consistency once fully dissolved, making it an easy pick for people who prefer a lighter protein drink
The conditions that most commonly support eligibility include: Obesity (BMI 30, or 27 with at least one comorbidity such as hypertension, sleep apnea, or cardiovascular disease) Type 2 diabetes or prediabetes Insulin resistance with clinical documentation Metabolic syndrome (clinically diagnosed) Polycystic Metabolic Ovarian Syndrome (PMOS) and related hormonal disorders Non-alcoholic fatty liver disease (NAFLD/MASLD) Perimenopause-related metabolic dysfunction with documented hormonal changes GLP-1 receptor agonists including semaglutide, tirzepatide, and retatrutide are the most commonly used peptides in metabolic care today
How often should GHK-Cu treatments be repeated
One user reported: "I have used GHK-cu injectable and topical and found no effect on E2 or DHT." The tradeoff is that GHK-Cu doesn't address the underlying hormonal cause of androgenetic alopecia
